Table 5.
Factors affecting eradication of Helicobacter pylori n (%)
| Factors | Eradicated | Not | Crude OR (95%CI) | P valuea | Adjust OR (95%CI) | P value1 |
| Age | 56.8 ± 12.9 | 57.6 ± 11.9 | 0.996 | 0.632 | ||
| (0.978-1.014) | ||||||
| Gender | ||||||
| Male | 294 | 34 | - | - | - | - |
| (61.25) | (39.53) | |||||
| Female | 186 | 52 | 0.414 | 0.080 | ||
| (38.75) | (60.47) | (0.259-0.662) | ||||
| Diagnosis | ||||||
| Gastric ulcer | 225 | 38 | 1.121 | 0.663 | ||
| (46.88) | (44.19) | (0.673-1.869) | ||||
| Duodenal ulcer | 86 | 16 | 1.018 | 0.896 | ||
| (17.92) | (18.60) | (0.529-1.957) | ||||
| Gastritis | 169 | 32 | - | - | ||
| (35.21) | (37.21) | |||||
| Treatment Group | ||||||
| PAC | 109 | 34 | - | - | - | - |
| (22.71) | (39.53) | |||||
| PAM | 117 | 22 | 1.659 | 0.430 | 1.738 | 0.559 |
| (24.38) | (25.58) | (0.914-3.012) | (0.948-3.187) | |||
| Sequential | 119 | 22 | 1.687 | 0.478 | 1.636 | 0.386 |
| (24.79) | (25.58) | (0.930-3.062) | (0.894-2.997) | |||
| Concomitant | 135 | 8 | 5.264 | 0.001 | 5.287 | 0.001 |
| (28.13) | (9.3) | (2.341-11.838) | (2.335-11.973) | |||
| Alcohol Intake | ||||||
| Yes | 165 | 27 | 1.145 | 0.591 | ||
| (34.38) | (31.4) | (0.699-1.874) | ||||
| No | 315 | 59 | - | - | ||
| (65.63) | (68.6) | |||||
| Smoking | ||||||
| Smoker | 127 | 18 | 1.359 | 0.281 | ||
| (26.46) | (20.93) | (0.778-2.374) | ||||
| Non-smoker | 353 | 68 | - | - | ||
| (73.54) | (79.07) | |||||
| BMI | 22.7 ± 2.7 | 22.2 ± 2.9 | 1.073 | 0.107 | ||
| (0.985-1.169) | ||||||
| Total Cholesterol | 188.2 ± 39.9 | 188.8 ± 35.1 | 1.000 | 0.914 | ||
| (0.993-1.007) | ||||||
| LDL Cholesterol | 107.3 ± 32.5 | 109.8 ± 31.8 | 0.998 | 0.601 | ||
| (0.989-1.007) |
1
P-value of Wald test for coefficients of logistic regression. PAC: Rabeprazole, amoxicillin, clarithromycin; PAM: Rabeprazole, amoxicillin, metronidazole; BMI: Body mass index; LDL: Low density lipoprotein.